Abbott Laboratories (ABT) Positioned to Benefit as Healthcare Sector Enters Recovery Phase
We recently compiled a list of the 10 best investments during a recession. The seventh stock on our list of best investments is Abbott Laboratories. TheFly reported on Jan. 9 that Bernstein analyst Lee Hambright raised ABT’s price target to $154 from $150, while maintaining an Outperform rating on the stock. The company noted that…